Time-action profile of insulin glargine (HOE901) in Japanese volunteers

被引：0
|
作者：
Rave, K
Heise, T
Heinemann, L
机构：
来源：
DIABETES | 2000年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1524
引用
收藏
页码：A363 / A363
页数：1
相关论文
共 50 条
  • [21] Tolerability and Time-Action Profile of Technosphere Insulin in Pediatric Subjects
    Jones, Marisa C.
    Haller, Michael J.
    Ng, Savannah E.
    Bhavsar, Sunil
    Kaiserman, Kevin B.
    Krueger, John A.
    DIABETES, 2021, 70
  • [22] Time-action profile of an inhaled insulin preparation in comparison to insulin Lispro and regular insulin
    Bott, S
    Heinemann, L
    Rave, K
    Sha, S
    Willavize, SA
    Carroll, RS
    Gruber, S
    Lee, JD
    Heise, T
    DIABETOLOGIA, 2000, 43 : A46 - A46
  • [23] HUMAN INSULIN ANALOG HOE901 - CHARACTERISTICS OF RECEPTOR-BINDING AND TYROSINE KINASE ACTIVATION
    BERTI, L
    SEFFER, E
    SEIPKE, G
    KRODER, G
    HARING, HU
    DIABETES, 1995, 44 : A243 - A243
  • [24] Time-action profile of an inhaled insulin preparation in comparison to insulin lispro and regular insulin
    Heise, T
    Rave, K
    Bott, S
    Sha, S
    Willavize, SA
    Carroll, RS
    Gruber, S
    Lee, JD
    Heinemann, L
    DIABETES, 2000, 49 : A10 - A10
  • [25] Time-action profile of the insulin analogue B28Asp
    Heinemann, L
    Kapitza, C
    Starke, AAR
    Heise, T
    DIABETIC MEDICINE, 1996, 13 (07) : 683 - 684
  • [26] HOE 901 (insulin glargine) improves satisfaction with intensified insulin treatment for type 1 diabetes.
    Witthaus, E
    Bradley, C
    Stewart, J
    DIABETOLOGIA, 1999, 42 : A235 - A235
  • [27] Time-Action Profile of Technosphere Insulin in Children with Type 1 Diabetes
    Haller, Michael J.
    Jones, Marisa C.
    Bhavsar, Sunil
    Kaiserman, Kevin B.
    DIABETES THERAPY, 2023, 14 (03) : 611 - 617
  • [28] Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin
    Rave, K
    Bott, S
    Heinemann, L
    Sha, S
    Becker, RHA
    Willavize, SA
    Heise, T
    DIABETES CARE, 2005, 28 (05) : 1077 - 1082
  • [29] Treatment with human analog (GlyA21, ArgB31, ArgB32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type 1 diabetes
    Moriyama, H
    Nagata, M
    Fujihira, K
    Yamada, K
    Chowdhury, SA
    Chakrabarty, S
    Jin, ZZ
    Yasuda, H
    Ueda, H
    Yokono, K
    DIABETES CARE, 2001, 24 (02) : 411 - 412
  • [30] A comparison of the pharmacodynamics (glucose lowering effect) of intravenous HOE901 and regular insulin using the euglycaemic clamp technique.
    Meyer, BH
    Scholtz, HE
    Pretorius, SG
    Van Niekerk, N
    Comm, M
    Rosenkranz, B
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 123 - 123
12345